研究期间均做同样的预防性抗凝治疗。
The prophylactic anticoagulation regimen was the same throughout the study period.
溶栓治疗和抗凝治疗可有效改善患者预后。
Thrombolytic therapy and anti-coagulation could effective improve the prognosis of PE patients.
美国应用抗凝药预防深静脉血栓的情况如何？
What is the status of anticoagulant for the prophylaxis of DVI in USA at present?
一些病人测试的时候要停用阿司匹林和抗凝药物。
Some patients were tested while discontinuing aspirin and anticoagulant therapies.
对于不同的患者，我们如何选择最佳的抗凝药物？
How do we choose optimal antithrombotic agents aimed at different patients?
《国际循环》：请您谈谈对ACS患者抗凝治疗的经验？
International Circulation: What is your experience with anticoagulation in ACS patients?
年龄的增加和控制心率药物的使用和抗凝治疗与否有关。
Increased age and use of rate control agents is associated with the use of anticoagulation.
早期手术及持续有效地抗凝治疗是降低本病死亡率的关键。
Early operation and continuous and effective anticoagulant therapy are the keys to decrease the mortality of the disease.
包括我的很多医生都会建议你使用一种抗凝药，比如华法林。
Many doctors, including me, would advise you to take an anticoagulant such as warfarin indefinitely.
目的：探讨不同的随访方式对苄丙酮香豆素钠抗凝疗效的影响。
Objective: To investigate the influence of the different style of follow-up visit to the anticoagulation effect of warfarin.
对机械瓣替换的儿童常规应用华法林抗凝能取得良好的远期效果。
Routine use of warfarin for anticoagulation in mechanical valve replacement children has proved safe and feasible in the long run.
目的探讨局部应用枸橼酸抗凝法行血液透析治疗的临床应用价值。
Objective To evaluate the clinical value of regional citrate anticoagulation to hemodialysis for patients with increased risk of bleeding.
2005年欧洲调查发现只有67%的房颤患者适宜接受抗凝治疗。
In 2005 the Euro Heart Survey AF found that only 67% of eligible patients were receiving anticoagulation.
使用抗血小板和抗凝药物是非常重要的，以尽量减少这些事件的发生。
The use of these anti-platelet and anticoagulant drugs is quite important to minimize these events.
在临床实践中，为预防卒中，我们如何权衡抗凝治疗的疗效和安全性？
In clinical practice, how do we weight efficacy and safety of anticoagulation therapy for preventing stroke?
为了减少华法林过弱或过强抗凝治疗的危险，这些差异必须给予考虑。
These differences must be taken into account when administering warfarin in order to minimize the risk of under- or over-anticoagulation.
因为DIC用光了抗凝因子和血小板，血液无法凝结，病人就会血流不止。
Because DIC used up coagulation factors and platelets, both necessary for blood to clot, the patient would begin to hemorrhage.
抗凝指南坚持在有中风的房颤患者中的应用——我们使用了“安全带”吗？
Antithrombotic guideline adherence in atrial fibrillation patients admitted with stroke. Do we use our safety belt?
PE大部分患者，我们不推荐在抗凝基础上常规放置腔静脉滤器(1A)。
For most patients with PE, we recommend against the routine use of a vena caval filter in addition to anticoagulants (Grade 1a).
《国际循环》：关于口服抗凝药治疗，我们如何保持安全性和有效性之间的平衡？
International Circulation: In oral anticoagulant therapy, how can we make the balance between safety and efficacy?
无症状PE患者，我们推荐同有症状患者采取相同起始和长程抗凝治疗(1c)。
In patients who are unexpectedly found to have asymptomatic PE, we recommend the same initial and long-term anticoagulation as for comparable patients with symptomatic PE (Grade 1c).
最大的变化是抗血小板药物的使用率增加，比如双重抗血小板治疗以及抗凝治疗。
The biggest change has been in the increased use of international therapy and anti-platelet agents as dual anti-platelet therapy, and antithrombotics.
现在大部分医生都建议这种接受药物涂层支架植入的患者不定期的服用抗凝药物。
Those who get drug-coated stents are now told by most doctors to take anti-clotting drugs indefinitely.
从这些试验的结果以及您个人的经验来看，对ACS患者最佳抗凝策略您有何理解？
From the results of these trials and your own experience, what is your understanding of the best anticoagulant strategy for patients presenting with ACS?
目的对心脏瓣膜置换术后早期抗凝的方法进行比较，以优化术后早期抗凝治疗方案。
Objective To compare the result of different anticoagulation methods after mechanical heart valve replacement in order to optimize the early-stage anticoagulation therapy.
结论疏血通注射液具有明显抗凝、促纤溶作用，对急性脑梗死的治疗和预防安全有效。
Conclusion Shuxuetong injection is effective and safe in treatment and prevention of acute cerebral infarction by accelerating fibrinolysis activity and inhibiting coagulation activity.
抗凝治疗对特发性肺动脉高压病人十分重要，但是在治疗ES方面存在争论，因为出血风险高。
Anticoagulants, which are an important part of therapy for many patients with idiopathic pulmonary hypertension, are controversial in ES, because of the high risk for bleeding complications.
摘要：目的：评价服用华法林患者的抗凝治疗质量，为加强服用华法林患者的管理提供数据支持。
ABSTRACT: OBJECTIVE: to evaluate the quality of anticoagulant therapy in patients who took warfarin and provide data supporting for strengthening the management of these patients.
结果应用脱水、抗凝及病因治疗等方法后，22例患者中17例基本痊愈，3例好转，2例死亡。
Results Of 22 cases treated with dehydration, anticoagulation and etiological treatment, there were 17 complete recovery, 3 improvement, and 2 dead.
结果应用脱水、抗凝及病因治疗等方法后，22例患者中17例基本痊愈，3例好转，2例死亡。
Results Of 22 cases treated with dehydration, anticoagulation and etiological treatment, there were 17 complete recovery, 3 improvement, and 2 dead.
应用推荐